Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5Endometrial Neoplasms 5Neoplasms 4Head and Neck Neoplasms 3Breast Neoplasms 3Rectal Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Pathologic Complete Response 1Ovarian Neoplasms 1Ovarian Carcinosarcoma 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Lung Neoplasms 1Laryngeal Diseases 1Hemangiosarcoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1

Interventions

pembrolizumab 8cemiplimab 5Nivolumab 4Ipilimumab 4Blood Specimen Collection 3lifileucel 2avelumab 2aldesleukin 2Niacinamide 2Cyclophosphamide 2toripalimab 1tislelizumab 1oxycodone-acetaminophen 1lenvatinib 1fludarabine 1epacadostat 1encorafenib 1durvalumab 1dostarlimab 1brodalumab 1binimetinib 1atezolizumab 1Vitamin A 1Surgical Procedures, Operative 1Sunscreening Agents 1Standard of Care 1Specimen Handling 1Resistance Training 1Radiotherapy 1Niacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × dostarlimab × 90 days × Clear all
NCT04387084 2026-03-23

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

University of Southern California

Phase 1 Active not recruiting
10 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡